NASDAQ: NEOG · Health Care / Biotechnology: In Vitro & In Vivo Diagnostic Substances

Neogen Corporation

How Neogen Corporation compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$2.7B

Price

$12.26

P/E

-47.7

EPS (TTM)

$-0.26

1-year return

96.8%

Dividend yield

0.0%

52-week range

$5.41–$12.80

Compared with

• Biotechnology: In Vitro & In Vivo Diagnostic Substances industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources